Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
Yu Yao(Fudan University), Liangfu Zhou(Fudan University), Yuting Deng(Shanghai Jiao Tong University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine), Yiwei Chu(Fudan University), Dave S.�B. Hoon(Saint John's Health Center), Ping Zhong(Jinan University), Jian Hu(The University of Texas MD Anderson Cancer Center), Wei Hua(Huashan Hospital), Dikang Chen(Fudan University), Di Chen(Fudan University), Yi Zhang(Tianjin Medical University General Hospital), Jiao Yang(Chinese Academy of Sciences), Zhiyong Qin(Fudan University), Ming Xu(China Pharmaceutical University), Xiujuan Zheng(Fudan University), Xiaojie Ding(Fudan University), Shuangquan Yu(Fudan University), Chao Tang(Fudan University), Jiawen Qian(Fudan University)
Cited by 109
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k